- Home
- DRDB vs CATX Comparison
DRDB vs CATX Comparison
Compare DRDB & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$3.23
Company Overview
Basic Information| Metric | DRDB | CATX |
|---|---|---|
| Founded | 2024 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.5M | 341.0M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DRDB | CATX |
|---|---|---|
| Price | $10.65 | $3.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | 84.0K | ★ 1.0M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $597.54 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.27 | $1.96 |
| 52 Week High | $10.65 | $6.16 |
Technical Indicators
Market Signals| Indicator | DRDB | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 68.77 | 58.45 |
| Support Level | $10.41 | $2.82 |
| Resistance Level | N/A | $4.27 |
| Average True Range (ATR) | 0.01 | 0.17 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 100.00 | 94.39 |
Price Performance
Historical Comparison DRDB
CATX
About DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.